Amgen (AMGN) Completes Acquisition of Ilypsa, Inc.
7/19/2007 12:18:33 PM
More...
|
Ilypsa, Inc. Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel
5/1/2007 12:15:04 PM
More...
|
Ilypsa, Inc. Completes Enrollment of Phase 2 Clinical Trial of ILY101 For Patients With Chronic Kidney Disease On Hemodialysis
2/6/2007 11:48:40 AM
More...
|
Ilypsa, Inc. Announces Promotion Of Gerrit Klaerner, Ph.D. To Senior Vice President And Chief Business Officer
12/12/2006 11:41:59 AM
More...
|
Ilypsa, Inc. Appoints Samuel R. Saks, M.D. To Board Of Directors
12/5/2006 10:55:02 AM
More...
|
Ilypsa, Inc. Announces Appointment Of William D. Waddill As Chief Financial Officer
10/26/2006 10:39:42 AM
More...
|
Ilypsa, Inc. And Astellas Pharma Inc. Enter A Licensing Agreement On ILY101 For Treatment Of Hyperphosphatemia In Japan; Astellas To Pay Ilypsa $92 Million
4/27/2006 11:23:51 AM
More...
|
Ilypsa, Inc. Completes Phase 1 Clinical Trial Of ILY101 For Hyperphosphatemia Associated With Chronic Kidney Disease
4/20/2006 12:01:48 PM
More...
|
Ilypsa, Inc. Announces Appointment Of Jay P. Shepard As President And CEO
1/5/2006 12:50:45 PM
More...
|
Ilypsa, Inc. Raises $36 Million For Kidney Drugs
10/19/2005 5:11:57 PM
More...
|
|